Upgrade Your Cell-based Assays to 3D!
InSphero Newsletter June 2013
"Hello! My name is Zoé Weydert. I’m working as an R&D Intern at InSphero and support the development of novel 3D microtissue models and liver toxicology studies. In September I will start my master in pharmaceutical biotechnology and I’m looking forward to doing my master thesis at InSphero."

InSphero featured in Tecan Journal

In the latest issue of the Tecan Journal InSphero‘s 3D microtissue technology is presented in combination with Tecan’s multimode reader Infinite 200 PRO, a system created for pharmaceutical and cosmetics companies to help reduce the costs and risks associated with drug development. View article.

InSphero Success Story by Euresearch

Euresearch has written a success story on InSphero and its collaborative research project “The Body-on-a-Chip” funded by the European Union. The project for next-generation drug screening device is coordinated by InSphero and developed together with leading academic and industrial partners. Read more.

3D Microtissues for advanced cardiotoxicity testing

InSphero is developing a 3D microtissue in vitro model for cardiotoxicity testing in collaboration with Christian Zuppinger from the University of Bern showing long term viability and contractile function for up to 3 weeks. Find out more and download poster.

InSphero secures CHF 2 Million Financing

To expand its rapidly growing business in the US and East Asia and to meet the increasing customer demand for its 3D microtissues InSphero successfully closed a financing round of CHF 2 million last month. Read more in media release.

3D cell culture literature picks – June 2013

Our applications team has reviewed a small selection of current 3D-cell-culture journal papers  to keep you updated about recent developments in 3D.
Copyright © 2013 InSphero, All rights reserved.